长期护理院临终症状管理药物处方与给药促进与障碍的定性研究
主题分析识别出四个主题:识别临终期与症状、医护人员之间及与家属的沟通、医护人员临终药物胜任力、以及支持给药的相关资源。
要点
- 长期护理院临终症状管理药物处方与给药存在明确挑战
- 识别临终期与症状是影响药物使用的首要主题
- 医护人员沟通与临终药物胜任力是关键促进与障碍因素
核心结论
- 长期护理院在临终症状管理药物的处方与给药方面存在明确挑战,研究结果可用于指导改善临终照护的干预措施。
主要发现
- 识别出四个影响临终症状管理药物处方与给药的主题:识别临终期与症状、医护人员之间及与家属的沟通、医护人员临终药物胜任力、支持给药的相关资源。
临床怎么用
- 研究结果可用于设计针对长期护理院临终症状管理药物处方与给药的改进干预,但需省级政府和长期护理部门的支持与投入。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Long-term care (LTC) homes provide personal and medical care 24/7 to individuals unable to live at home due to illness or disability and are often the final place of care and death for their residents. Therefore, LTC homes are tasked with providing quality end-of-life care, often requiring injectable symptom management medications to relieve distressing symptoms (eg, pain). In this study, we aimed to understand the enablers and barriers to prescribing and administering end-of-life symptom management medications in LTC homes. DESIGN: Qualitative study. SETTING AND PARTICIPANTS: From February 2021 to December 2022, we conducted virtual semi-structured interviews with health care providers (physicians and nurses) who worked in Ontario LTC homes and family caregivers of residents who died in LTC. METHODS: We analyzed interview transcripts using thematic analysis. RESULTS: We identified 4 themes related to factors that may impact the prescribing and administering of medications for end-of-life symptom management: (1) identifying the end-of-life period and symptoms, (2) communication among health care providers and between health care providers and family caregivers, (3) health care provider competency with end-of-life medications, and (4) resources for LTC staff to support medication prescribing and administrating. CONCLUSIONS AND IMPLICATIONS: In LTC, there are distinct challenges in the prescribing and administrating of end-of-life symptom management medications. Our findings can be used to inform interventions aimed at improving end-of-life care for LTC residents. However, these interventions require buy-in and investment from the provincial government and the LTC sector.
引用
- Roberts RL, Milani C, Webber C, et al. Enablers and Barriers for End-of-Life Symptom Management Medications in Long-Term Care Homes: A Qualitative Study. J Am Med Dir Assoc. 2024. PMID: 38857683. doi:10.1016/j.jamda.2024.105076
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。